AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule ...

AN2 Therapeutics said it was planning to meet with the U.S. Food and Drug Administration to discuss a development path for epetraborole, a treatment of non-tuberculous mycobacterial lung disease. The ...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...

Chesapeake Gold Corp. TSX-Venture Symbol: CKG All Issues: Yes Reason: Pending News Halt Time (ET): 3:39 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS – ...

AN2 Therapeutics Inc (NASDAQ: ANTX) has experienced a decline in its stock price by 0.00 compared to its previous closing price of 1.10. However, the company has seen a gain of 1.85% in its stock ...

The experts were also involved in the “Digital Therapeutics for Italy - #DTxITA”, established in 2019 to encourage the implementation of DTx in Italian institutions and healthcare systems.

Welcome to the 3 rd Annual RNAi – Based Therapeutics Summit: Overcoming Barriers for Targeted siRNA Therapeutics Built with biopharmaceutical industry insights, this in person conference will ...

We currently have no ANTX Stock Split History on this stock.

When is the Path of Exile 2 release date? Path of Exile 2 has now evolved from its initial role as effectively a large expansion to become its own full game, with completely new mechanics, classes ...

After hours: November 13 at 4:47 PM EST Loading Chart for PSTV ...

Dyne Therapeutics Inc. 4.27% $2.94B ...